Efficacy and Safety of Corticosteroids in COVID-19

Efficacy and Safety of Corticosteroids in COVID-19: A Prospective Randomized Controlled Trails

There is still controversy about the effective of glucocorticoids for the treatment of novel coronavirus pneumonia. This is a prospective randomized controlled trails. The aim is to explore the effectiveness and safety of glucocorticoids in the treatment of novel coronavirus pneumonia.

Inclusion Criteria:

• age more than 18 years old
• accord with the clinical diagnosis and/ or etiological diagnosis diagnostic criteria of Novel coronavirus pneumonia (COVID-19).
• admitted in the general wards
• be able to sign informed consent

Exclusion Criteria:

• severe immunosuppression (HIV infection, long-term use of immunosuppressive agents
• pregnant or lactation period women
• glucocorticoids are needed for other diseases
• unwilling or unable to participate or complete the study
• participate in other study